AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

STARPHARMA HOLDINGS LTD

0.730

-0.030-3.95%

Volume:3.49M

Turnover:2.57M

Market Cap:348.25M

PE:-94.57

High:0.780

Open:0.750

Low:0.727

Close:0.760

52wk High:0.815

52wk Low:0.107

Shares:477.05M

Float Shares:347.84M

Volume Ratio:1.42

T/O Rate:1.00%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.008

EPS(LYR):-0.024

ROE:-14.47%

ROA:-7.24%

PB:16.21

PE(LYR):-30.49

Loading ...

Overview Company News Filings

Company Profile

Company Name:

STARPHARMA HOLDINGS LTD

Exchange:

ASX

Establishment Date:

1997

Employees:

40

Office Location:

4-6 Southampton Crescent,Abbotsford,Victoria,Australia

Website:

http://starpharma.com

Zip Code:

3067

Phone:

Fax:

61 3 9510 5955

Introduction:

Starpharma Holdings Limited engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company focuses on the development of VivaGel, which has completed Phase III clinical trials for the management and prevention of bacterial vaginosis, and as a condom coating for the prevention of sexually transmitted infections, as well as VivaGel condom, an antiviral condom. It also develops DEP, a dendrimer drug delivery technology, including DEP docetaxel that is in Phase II clinical trials, DEP cabazitaxel that is in Phase 1/2 clinical trial, and DEP irinotecan that is in phase 1/2 clinical trials for the treatment of solid tumors. The company was founded in 1996 and is headquartered in Abbotsford, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/SPL.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"SPL.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"SPL.AU\",,,,,undefined,":{"symbol":"SPL.AU","market":"AU","secType":"STK","nameCN":"STARPHARMA HOLDINGS LTD","latestPrice":0.73,"timestamp":1787292720000,"preClose":0.76,"halted":0,"volume":3486167,"delay":0,"changeRate":-0.03947368421052635,"nameEN":"STARPHARMA HOLDINGS LTD","floatShares":347835291,"shares":477054949,"eps":-0.007719,"marketStatus":"Market Closed","change":-0.03,"latestTime":"08-21 16:12:00 AEST","open":0.75,"high":0.78,"low":0.727,"amount":2574837,"amplitude":0.069737,"askPrice":0.76,"askSize":13000,"bidPrice":0.725,"bidSize":1379,"shortable":3,"etf":0,"ttmEps":-0.007719,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1787529600000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.76,"openAndCloseTimeList":[[1787270400000,1787292000000]],"volumeRatio":1.4190131159906167,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"SPL.AU","preClose":0.76,"auctionPrice":0.735,"auctionVolume":278374,"auction":3,"marketStatus":"盘后竞价","timestamp":1787292600774}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"SPL.AU\",,,,,undefined,":{"symbol":"SPL.AU","floatShares":347835291,"roa":"-7.24%","roe":"-14.47%","lyrEps":-0.023946,"volumeRatio":1.4190131159906167,"shares":477054949,"dividePrice":0,"high":0.78,"amplitude":0.069737,"preClose":0.76,"low":0.727,"week52Low":0.107,"pbRate":"16.21","psRate":"23.89","week52High":0.815,"institutionHeld":0,"latestPrice":0.73,"committee":-0.808193,"eps":-0.007719,"divideRate":0,"volume":3486167,"delay":0,"ttmEps":-0.007719,"open":0.75,"prevYearClose":0.351,"prevWeekClose":0.725,"prevMonthClose":0.75,"prevQuarterClose":0.682,"fiveDayClose":0.725,"twentyDayClose":0.69,"sixtyDayClose":0.658},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SPL.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2026-07-17","symbol":"SPL.AU","defaultRemindTime":1784246400000,"type":"split","dateTimestamp":1784210400000,"forFactor":974214,"toFactor":1000000,"ratio":0.974214}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SPL.AU\",market:\"AU\",,,undefined,":[],"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":4493458,"yearFounded":1997,"employeeNum":40,"address":"4-6 Southampton Crescent,Abbotsford,Victoria,Australia","zipCode":"3067","officePhone":"61 3 8532 2700","officeFax":"61 3 9510 5955","fiscalYearEnd":"06-30"},"stockCompanyDetail":{"websiteUrl":"http://starpharma.com","stockEarnings":[{"period":"1week","weight":0.0069},{"period":"1month","weight":0.0504},{"period":"3month","weight":0.2086},{"period":"6month","weight":0.499},{"period":"1year","weight":4.5303},{"period":"ytd","weight":1.0798}],"compareEarnings":[{"period":"1week","weight":-0.0013},{"period":"1month","weight":0.0219},{"period":"3month","weight":0.0512},{"period":"6month","weight":0.0313},{"period":"1year","weight":0.0865},{"period":"ytd","weight":0.0535}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Starpharma Holdings Limited engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company focuses on the development of VivaGel, which has completed Phase III clinical trials for the management and prevention of bacterial vaginosis, and as a condom coating for the prevention of sexually transmitted infections, as well as VivaGel condom, an antiviral condom. It also develops DEP, a dendrimer drug delivery technology, including DEP docetaxel that is in Phase II clinical trials, DEP cabazitaxel that is in Phase 1/2 clinical trial, and DEP irinotecan that is in phase 1/2 clinical trials for the treatment of solid tumors. The company was founded in 1996 and is headquartered in Abbotsford, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.538462,"avgChangeRate":0.019366},{"month":2,"riseRate":0.346154,"avgChangeRate":-0.019367},{"month":3,"riseRate":0.384615,"avgChangeRate":0.02555},{"month":4,"riseRate":0.307692,"avgChangeRate":-0.017937},{"month":5,"riseRate":0.346154,"avgChangeRate":-0.039405},{"month":6,"riseRate":0.576923,"avgChangeRate":0.041309},{"month":7,"riseRate":0.423077,"avgChangeRate":0.003077},{"month":8,"riseRate":0.68,"avgChangeRate":0.099247},{"month":9,"riseRate":0.5,"avgChangeRate":0.017785},{"month":10,"riseRate":0.461538,"avgChangeRate":-0.016562},{"month":11,"riseRate":0.5,"avgChangeRate":0.028116},{"month":12,"riseRate":0.461538,"avgChangeRate":-0.006043}],"exchange":"ASX","name":"STARPHARMA HOLDINGS LTD","nameEN":"STARPHARMA HOLDINGS LTD"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"SPL.AU\",market:\"AU\",,,undefined,":null}}